Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Hair thickness differences help diagnose hair loss severity.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Hair loss in Androgenetic Alopecia is not caused by damage to follicular stem cells.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

FAGA shows varied hair thickness, while TE has more empty follicles.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

Two Sikh brothers developed permanent hair loss from wearing turbans tightly, a condition that became apparent after they moved to Austria.

Caffeine improves hair growth, thickness, and reduces shedding.

Hair loss without scarring is more common than permanent hair loss with scarring, and is often due to genetic factors.

Using one's own fat may help treat hair loss.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

The document suggests a new way to categorize skin and mind disorders into two main groups to reduce confusion.

Effective treatment of folliculitis decalvans requires accurate diagnosis and more research for better therapies.

Finasteride and minoxidil are effective for hair loss, with potential side effects, and JAK inhibitors show promise for alopecia areata.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Immune activities and specific genes are important in male pattern baldness.

A man with rare Lichen Planopilaris lost body hair, not scalp hair, and treatment stopped itching but didn't regrow hair.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).